PHARMACIE DEPREZ
ActiveSummary
PHARMACIE DEPREZ has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €556k and a net result of €85k. Equity is growing by ~19.7% per year across the filed fiscal years. Its solvency ranks better than 52% of 4157 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76=
Solvency63▲+7
Growth78=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity tight (current ratio 1.17 against 1.0 in 2024; short-term debt: 18.7% and cash: 5.6% of total assets), and 62.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
37.6%
Return on assets
5.8%
Age of the figures
18 mo
neutral · Filed after the deadline
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 20-11-2025, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
20 d late
2024
14 d late
2023
23 d late
2022
17 d late
2021
19 d late
2020
32 d early
2019
14 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close24-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€85k▼ 7.8%
2024 · €93k
2019: €77k
2020: €56k
2021: €65k
2022: €51k
2023: €51k
2024: €93k
2019 → 2025
Working capital
€48k
2024 · €-1k
2019: €40k
2020: €42k
2021: €22k
2022: €5k
2023: €-14k
2024: €-1k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€277k-€328k▲ 18.3%€378k▲ 15.4%€471k▲ 24.5%€556k▲ 18.2%
Operating result€101k-€90k▼ 11.4%€90k▲ 0.5%€145k▲ 60.6%€131k▼ 9.8%
Net result€65k-€51k▼ 21.6%€51k▼ 0.5%€93k▲ 83.5%€85k▼ 7.8%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 10% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.48M
Fixed assets
€1.16M ▼ 4.1%
Current assets
€325k ▲ 9.3%
Equity and liabilities €1.48M
Equity
€556k ▲ 18.2%
Debt
€925k ▼ 10.4%
Debt's share of the balance-sheet total falls from 68.7% to 62.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€168k▼
2024 · €183k
Cash flow
€123k▼
2024 · €131k
Current ratio
1.17▲
2024 · 1.00
Quick ratio
0.69▲
2024 · 0.55
Debt to equity
1.66▼
2024 · 2.19
ROE
15.4%▼
2024 · 19.7%
ROA
5.8%▼
2024 · 6.2%
Interest coverage
8.45=
2024 · 8.45
Debt ≤ 1 year
€277k▼
2024 · €298k
Debt > 1 year
€648k▼
2024 · €735k
Income taxes
€25k▼
2024 · €30k
Staff costs
€216k▲
2024 · €185k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.50M€1.48M▼
Formation expenses20€0€0=
Fixed assets21/28€1.21M€1.16M▼
Intangible fixed assets21€717k€712k▼
Tangible fixed assets22/27€490k€445k▼
Land and buildings22€444k€418k▼
Plant, machinery and equipment23€25k€21k▼
Furniture and vehicles24€20k€5k▼
Financial fixed assets28€374€374=
Current assets29/58€297k€325k▲
Stocks and contracts in progress3€132k€135k▲
Stocks30/36€132k€135k▲
Amounts receivable within one year40/41€116k€97k▼
Trade receivables40€113k€97k▼
Other amounts receivable41€3k€5▼
Cash at bank and in hand54/58€40k€83k▲
Deferred charges and accrued income490/1€9k€9k▼
Equity and liabilities
Total equity and liabilities10/49€1.50M€1.48M▼
Equity10/15€471k€556k▲
Contributions10/11€12k€12k=
Reserves13€20k€20k=
Distributable reserves133€20k€20k=
Profit (loss) carried forward14€439k€524k▲
Amounts payable17/49€1.03M€925k▼
Amounts payable after more than one year17€735k€648k▼
Financial debts170/4€735k€648k▼
Amounts payable within one year42/48€298k€277k▼
Current portion of amounts payable after more than one year42€104k€111k▲
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€147k€118k▼
Suppliers440/4€147k€118k▼
Taxes, remuneration and social security45€43k€44k▲
Taxes450/3€15k€9k▼
Remuneration and social security454/9€28k€35k▲
Other amounts payable47/48€4k€4k▼
Income statement
Code20242025
Remuneration, social security and pensions62€185k€216k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€38k€37k▼
Other operating charges640/8€3k€4k▲
Gross operating margin9900€371k€388k▲
Operating profit (loss)9901€145k€131k▼
Financial income75/76B€84€176▲
Recurring financial income75€84€176▲
Financial charges65/66B€22k€20k▼
Recurring financial charges65€22k€20k▼
Profit (loss) for the period before taxes9903€123k€111k▼
Income taxes67/77€30k€25k▼
Profit (loss) for the period9904€93k€85k▼
Profit (loss) for the period to be appropriated9905€93k€85k▼
Appropriation of the result
Profit (loss) to be appropriated9906€439k€524k▲
Profit (loss) brought forward from the previous period14P€346k€439k▲
Social balance
Average headcount (FTE)90874.94.7▼
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
20-11
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 20 days late
31-03
Financial
Equity above €500kEq €556k ▲18.2%
7 profitable years in a row build equity to €556k.
2024
14-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 14 days late
31-03
Financial
Highest result since 2019net €93k ▲83.5%
Operating result €145k, net result €93k, both a record.
2023
23-11
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 23 days late
31-03
Financial
Weakest financial yearnet €51k ▼0.5%
Net result drops to €51k, the lowest in the series; recovery starts the following year.
2022
17-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 17 days late
2021
19-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 19 days late
2020
29-09
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
31-03
Financial
Equity above €200kEq €212k ▲35.7%
2 profitable years in a row build equity to €212k.
2019
14-11
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 14 days late
2018
26-11
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Courcelles 1006044 CharleroiGround area
870 m²
Building footprint
134 m²
Volume, LiDAR
1,241 m³
Parcel 52061A0377/00A002, Wallonia · tallest building 10.8 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE DEPREZ
since 20172.261.747.515
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52061A0377/00A002 | Wallonia | 870 m² | 1 · 134 m² | 10.8 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteCharleroi2.261.747.515
Similar companies · same sector, comparable size
MRZK Pharma
BE 0439.203.330
Hamme (Vl.) · Eq €556,284
Pharmacie dejardin
BE 0446.901.764
Beauraing · Eq €556,154
P.J. VLEUGELS et Cie
BE 0416.084.270
Frameries · Eq €556,574
Apotheek Heleen Mylle
BE 0811.322.945
Anzegem · Eq €557,057
LS Pharma
BE 0779.459.534
Gembloux · Eq €555,475
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,314 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded22-02-2017
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.